Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 28, 2020
Impact of newborn screening and quality of therapy on the neurological outcome in glutaric aciduria type 1: a meta-analysisNikolas Boy, Katharina Mengler, Jana Heringer-Seifert, et al.Journal of Inherited Metabolic Disease|April 30, 2022
How longitudinal observational studies can guide screening strategy for rare diseasesUlrike Mütze, Katharina Mengler, Nikolas Boy, et al.Vaccines|June 24, 2022
A Needs-Based Analysis of Teaching on Vaccinations and COVID-19 in German Medical SchoolsFranziska Baessler, Ali Zafar, Katharina Mengler, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 21, 2024
Impact of early diagnosis, disease variant, and quality of care on the neurocognitive outcome in maple syrup urine disease: A meta-analysisSvenja Scharre, Katharina Mengler, Elena Schnabel, et al.Pediatrics|March 18, 2025
Long-Term Outcomes of Adolescents and Young Adults Identified by Metabolic Newborn ScreeningUlrike Mütze, Julia Stengel, Florian Gleich, et al.Journal of Inherited Metabolic Disease|April 2, 2024
Outcomes after newborn screening for propionic and methylmalonic acidemia and homocystinuriasAnna T Reischl-Hajiabadi, Elena Schnabel, Florian Gleich, et al.Annals of Neurology|April 18, 2018
Newborn screening: A disease-changing intervention for glutaric aciduria type 1Nikolas Boy, Katharina Mengler, Eva Thimm, et al.Pediatrics|July 3, 2024
Treatment Outcomes for Maple Syrup Urine Disease Detected by Newborn ScreeningKatharina Mengler, Sven F Garbade, Florian Gleich, et al.Journal of Inherited Metabolic Disease|December 4, 2020
Impact of interventional and non-interventional variables on anthropometric long-term development in glutaric aciduria type 1: A national prospective multi-centre studyE M Charlotte Märtner, Esther M Maier, Katharina Mengler, et al.Pageof 1